NO972043L - Tienopyridin eller tienopyrimidinderivater og deres anvendelse - Google Patents

Tienopyridin eller tienopyrimidinderivater og deres anvendelse

Info

Publication number
NO972043L
NO972043L NO972043A NO972043A NO972043L NO 972043 L NO972043 L NO 972043L NO 972043 A NO972043 A NO 972043A NO 972043 A NO972043 A NO 972043A NO 972043 L NO972043 L NO 972043L
Authority
NO
Norway
Prior art keywords
tienopyridine
thienopyrimidine derivatives
thienopyridine
bone resorption
thienopyrimidine
Prior art date
Application number
NO972043A
Other languages
English (en)
Other versions
NO972043D0 (no
Inventor
Takashi Sohda
Haruhiko Makino
Atsuo Baba
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO972043D0 publication Critical patent/NO972043D0/no
Publication of NO972043L publication Critical patent/NO972043L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det ble beskrevet et antiinflammatorisk middel, spesielt et middel for behandling av artritt, og et benresorpsjons- inhiberende middel, inneholdende et tienopyridin- eller et tienopyrimidinderivat eller et salt derav. Det ble også frem- skaffet et nytt tienopyridin- eller et tienopyrimidinderivat med antiinflammatorisk aktivitet og benresorpsjonsinhiberende aktivitet.
NO972043A 1994-11-08 1997-05-02 Tienopyridin eller tienopyrimidinderivater og deres anvendelse NO972043L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP27380194 1994-11-08
JP32005594 1994-12-22
PCT/JP1995/002271 WO1996014319A1 (en) 1994-11-08 1995-11-07 Thienopyridine or thienopyrimidine derivatives and their use

Publications (2)

Publication Number Publication Date
NO972043D0 NO972043D0 (no) 1997-05-02
NO972043L true NO972043L (no) 1997-06-25

Family

ID=26550777

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972043A NO972043L (no) 1994-11-08 1997-05-02 Tienopyridin eller tienopyrimidinderivater og deres anvendelse

Country Status (12)

Country Link
US (1) US5747486A (no)
EP (1) EP0791000B1 (no)
KR (1) KR970707131A (no)
AT (1) ATE225351T1 (no)
AU (1) AU699354B2 (no)
CA (1) CA2202985A1 (no)
DE (1) DE69528470T2 (no)
FI (1) FI971974A7 (no)
HU (1) HUT77348A (no)
NO (1) NO972043L (no)
NZ (1) NZ294933A (no)
WO (1) WO1996014319A1 (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU715100B2 (en) * 1996-04-25 2000-01-13 Takeda Chemical Industries Ltd. Thienopyridine derivatives and their use
US6727258B2 (en) 1997-10-29 2004-04-27 King Pharmaceutical Research & Development, Inc. Allosteric adenosine receptor modulators
US5939432A (en) * 1997-10-29 1999-08-17 Medco Research, Inc. Thiophenes useful for modulating the adenosine receptor
US6323214B1 (en) 1997-10-29 2001-11-27 Medco Research, Inc Allosteric adenosine receptor modulators
US6232320B1 (en) 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
TW564247B (en) 1999-04-08 2003-12-01 Akzo Nobel Nv Bicyclic heteraromatic compound
TW591031B (en) * 2000-02-29 2004-06-11 Takeda Chemical Industries Ltd Thienopyridine derivatives, their production and use
US6503914B1 (en) 2000-10-23 2003-01-07 Board Of Regents, The University Of Texas System Thienopyrimidine-based inhibitors of the Src family
WO2002064598A1 (en) * 2001-02-14 2002-08-22 Warner-Lambert Company Llc Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors
WO2003018590A1 (fr) * 2001-08-24 2003-03-06 Takeda Chemical Industries, Ltd. Procede de production d'un derive de la thienopyridine
US7049333B2 (en) 2002-06-04 2006-05-23 Sanofi-Aventis Deutschland Gmbh Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
AU2003281170A1 (en) * 2002-07-17 2004-02-02 Warner-Lambert Company Llc Pharmaceutical compostions comprising an allosteric carboxylic inhibitor of matrix metalloproteinase-13 and a selective inhibitor of cyclooxygenase-2
AR044743A1 (es) * 2002-09-26 2005-10-05 Nihon Nohyaku Co Ltd Herbicida, metodo de emplearlo, derivados de tienopirimidina sustituida,compuestos intermediarios, y procedimientos que se utilizan para producirlos,
WO2005003100A2 (en) * 2003-07-03 2005-01-13 Myriad Genetics, Inc. 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
WO2006074147A2 (en) 2005-01-03 2006-07-13 Myriad Genetics, Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
MX2007007026A (es) * 2004-12-17 2007-07-04 Hoffmann La Roche Derivados de tieno-piridina como intensificadores alostericos de gaba-b.
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CN101189208A (zh) 2005-06-02 2008-05-28 弗·哈夫曼-拉罗切有限公司 作为gaba-b增强剂的3-甲磺酰基喹啉
WO2007056214A2 (en) * 2005-11-02 2007-05-18 Cytovia, Inc N-alkyl-n-aryl-thienopyrimidin-r-amines and uses thereof
WO2007056208A2 (en) * 2005-11-02 2007-05-18 Cytovia, Inc. N-arylalkyl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
US20070099877A1 (en) * 2005-11-02 2007-05-03 Cytovia, Inc. N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
EP2574610A1 (en) * 2007-11-15 2013-04-03 Gilead Sciences, Inc. Inhibitors of human immonodeficiency virus replication
US8575403B2 (en) 2010-05-07 2013-11-05 Celanese International Corporation Hydrolysis of ethyl acetate in ethanol separation process
US8859827B2 (en) 2011-11-18 2014-10-14 Celanese International Corporation Esterifying acetic acid to produce ester feed for hydrogenolysis
US8846988B2 (en) 2010-07-09 2014-09-30 Celanese International Corporation Liquid esterification for the production of alcohols
WO2012148509A1 (en) 2011-04-26 2012-11-01 Celanese International Corporation Process for producing ethanol using a stacked bed reactor
US8664454B2 (en) 2010-07-09 2014-03-04 Celanese International Corporation Process for production of ethanol using a mixed feed using copper containing catalyst
US9272970B2 (en) 2010-07-09 2016-03-01 Celanese International Corporation Hydrogenolysis of ethyl acetate in alcohol separation processes
US8710279B2 (en) 2010-07-09 2014-04-29 Celanese International Corporation Hydrogenolysis of ethyl acetate in alcohol separation processes
US8592635B2 (en) 2011-04-26 2013-11-26 Celanese International Corporation Integrated ethanol production by extracting halides from acetic acid
US8907141B2 (en) 2011-04-26 2014-12-09 Celanese International Corporation Process to recover alcohol with secondary reactors for esterification of acid
US9000233B2 (en) 2011-04-26 2015-04-07 Celanese International Corporation Process to recover alcohol with secondary reactors for hydrolysis of acetal
US9073816B2 (en) 2011-04-26 2015-07-07 Celanese International Corporation Reducing ethyl acetate concentration in recycle streams for ethanol production processes
US8754268B2 (en) 2011-04-26 2014-06-17 Celanese International Corporation Process for removing water from alcohol mixtures
US8895786B2 (en) 2011-08-03 2014-11-25 Celanese International Corporation Processes for increasing alcohol production
US8802901B2 (en) 2011-11-18 2014-08-12 Celanese International Corporation Continuous ethyl acetate production and hydrogenolysis thereof
US8829249B2 (en) 2011-11-18 2014-09-09 Celanese International Corporation Integrated esterification and hydrogenolysis process for producing ethanol
US8829251B2 (en) 2011-11-18 2014-09-09 Celanese International Corporation Liquid esterification method to produce ester feed for hydrogenolysis
US8748673B2 (en) 2011-11-18 2014-06-10 Celanese International Corporation Process of recovery of ethanol from hydrogenolysis process
US9024089B2 (en) 2011-11-18 2015-05-05 Celanese International Corporation Esterification process using extractive separation to produce feed for hydrogenolysis
US8853468B2 (en) 2011-11-18 2014-10-07 Celanese International Corporation Vapor esterification method to produce ester feed for hydrogenolysis
US8927790B2 (en) 2011-12-15 2015-01-06 Celanese International Corporation Multiple vapor feeds for hydrogenation process to produce alcohol
US8975451B2 (en) 2013-03-15 2015-03-10 Celanese International Corporation Single phase ester feed for hydrogenolysis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5143796A (ja) * 1974-10-09 1976-04-14 Yoshitomi Pharmaceutical Shinkinachenopirimijinruino seizoho
JPS5246095A (en) * 1975-10-07 1977-04-12 Yoshitomi Pharmaceut Ind Ltd Preparation of novel thienopyrimidine derivatives
DE3502392A1 (de) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen

Also Published As

Publication number Publication date
EP0791000A1 (en) 1997-08-27
KR970707131A (ko) 1997-12-01
US5747486A (en) 1998-05-05
WO1996014319A1 (en) 1996-05-17
CA2202985A1 (en) 1996-05-17
FI971974L (fi) 1997-06-18
DE69528470D1 (de) 2002-11-07
ATE225351T1 (de) 2002-10-15
NO972043D0 (no) 1997-05-02
DE69528470T2 (de) 2003-08-21
AU699354B2 (en) 1998-12-03
AU3815895A (en) 1996-05-31
NZ294933A (en) 1999-05-28
EP0791000B1 (en) 2002-10-02
HUT77348A (hu) 1998-03-30
FI971974A0 (fi) 1997-05-07
FI971974A7 (fi) 1997-06-18

Similar Documents

Publication Publication Date Title
NO972043D0 (no) Tienopyridin eller tienopyrimidinderivater og deres anvendelse
NO991951L (no) Tienopyrimidiner med fosfodiesterase V-inhiberende virkning
NO992821L (no) Ketobenzamider som calpain-inhibitorer
NO972972L (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
NO963860L (no) Isoprenyl-transferase-inhibitorer
NO992492L (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
FI954718A0 (fi) Heterosykliset johdannaiset iskeemian ja vastaavien sairauksien hoitamiseksi
DK620489D0 (da) Enzymhaemmende urinstofderivater af dipeptider, deres fremstilling og anvendelse som laegemidler
NO951900L (no) Stilkskrue og bakenforliggende spinalinstrumentering
FI962559A7 (fi) Hormonaaliseen raskauden ehkäisyyn ja/tai aknen hoitoon tarkoitettu lääke ja menetelmä
IS1839B (is) Píperasín afleiður sem hafa verkjastillandi áhrif, framleiðsla og notkun þeirra
ATE231837T1 (de) Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung
DE69313097D1 (de) Chirurgische und/oder klinische vorrichtung.
NO975710L (no) Nye Dolastatinderivater, deres fremstilling og anvendelse
AP9100310A0 (en) Tnf inhibitors
FI962022L (fi) 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
AU6484994A (en) Seed treatment using phosphorous acid or one of its salts, and seeds thus treated
EP0678031A4 (en) TISSUE GROWTH INHIBITORS FROM TISSUE, METHODS FOR THEIR PRODUCTION AND USE THEREOF.
PL310348A1 (en) Substituted derivatives of azolone for use in treating diseases caused by heliobacter
NO20016201L (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
IS3951A (is) Cephalosporinafleiður, aðferð til framleiðslu þeirra og notkunar sem lyfja
FI891813L (fi) Mikro-organismeja tappava/mikro-organismien kasvua estävä koostumus teollista käyttöä varten sekä menetelmä mikro-organismien tappamiseksi tai niiden kasvun estämiseksi
NO953673L (no) [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse
EP0351354A3 (en) Somatostatin derivatives for the treatment of arthritis
NZ331802A (en) Thienopyridine derivatives and their use as an anti-inflammatory drug for preventing or treating arthritis and inhibiting bone resorption

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application